A detailed history of Capital Analysts, LLC transactions in Sanofi stock. As of the latest transaction made, Capital Analysts, LLC holds 1,537 shares of SNY stock, worth $74,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,537
Previous 77 1896.1%
Holding current value
$74,206
Previous $4,000 2100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$48.54 - $58.53 $70,868 - $85,453
1,460 Added 1896.1%
1,537 $88,000
Q2 2024

Aug 14, 2024

BUY
$45.39 - $50.36 $953 - $1,057
21 Added 37.5%
77 $4,000
Q4 2023

Jan 30, 2024

BUY
$43.13 - $54.79 $1,811 - $2,301
42 Added 300.0%
56 $3,000
Q3 2023

Nov 13, 2023

BUY
$50.95 - $55.2 $713 - $772
14 New
14 $1,000
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $3,200 - $8,643
86 New
86 $3,000
Q3 2021

Nov 04, 2021

SELL
$47.89 - $53.12 $7,518 - $8,339
-157 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$49.36 - $54.25 $5,478 - $6,021
111 Added 241.3%
157 $8,000
Q4 2020

Feb 16, 2021

BUY
$45.3 - $51.62 $2,083 - $2,374
46 New
46 $2,000
Q1 2020

May 08, 2020

SELL
$38.02 - $51.66 $988 - $1,343
-26 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$44.25 - $50.86 $1,150 - $1,322
26 New
26 $1,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.